[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334645-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334645-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-expression-of-the-claudin-family-of-proteins-in-colorectal-cancer-review","The Expression of the Claudin Family of Proteins in Colorectal Cancer - Review","","Claudins (CLDN1–CLDN24) are tight junction proteins whose altered expression contributes to tumorigenesis across cancer types. In colorectal cancer (CRC), CLDN1, CLDN2, CLDN4, and CLDN18 show dysregulated or aberrant expression, while normal colon tissue expresses CLDN1 and CLDN3–7. Some claudins, including CLDN6 and CLDN7, are present in CRC but reduced relative to normal colon. This review summarizes claudin expression profiles in CRC and evaluates claudins with potential value as biomarkers for prognostication.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-expression-of-the-claudin-family-of-proteins-in-colorectal-cancer-review/334645/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-expression-of-the-claudin-family-of-proteins-in-colorectal-cancer-review/334645.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which claudins are highlighted as dysregulated in colorectal cancer?","Question",{"text":63,"@type":64},"CLDN1, CLDN2, CLDN4, and CLDN18 are described as upregulated or aberrantly expressed in colorectal cancer. Some claudins such as CLDN6 and CLDN7 are also expressed but at reduced levels compared with normal colon.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the reported expression pattern of claudins in normal colon?",{"text":68,"@type":64},"In normal colon, CLDN1 and CLDN3–7 are expressed. By contrast, CRC shows altered expression across several claudin subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the review assess claudins as prognostic biomarkers in CRC?",{"text":72,"@type":64},"The review outlines claudin expression profiles in CRC and focuses on claudins that have been proposed as potential biomarkers for prognostication, linking differential expression patterns to outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334645,1790164702,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":99,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","biomolecules  \nReview  \nThe Expression of the Claudin Family of Proteins in Colorectal Cancer  \nKristin E. Cox 1,2, Shanglei Liu 1, Robert M. Hoffman 1,2,3, Surinder K. Batra 4, Punita Dhawan 4 and Michael Bouvet 1,2, *  \nCitation: Cox, K.E.; Liu, S.; Hoffman, R.M.; Batra, S.K.; Dhawan, P.; Bouvet, M. The Expression of the Claudin Family of Proteins in Colorectal Cancer. Biomolecules 2024, 14, 272 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biom14030272  \nAcademic Editor: Tracey Martin  \nReceived: 5 February 2024  \nRevised: 20 February 2024  \nAccepted: 21 February 2024  \nPublished: 24 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Surgery, University of California San Diego, La Jolla, CA 92037, USA  \n2 VA San Diego Healthcare System, La Jolla, CA 92161, USA  \n3 AntiCancer, Inc., San Diego, CA 92111, USA  \n4 Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA; [sbatra@unmc.edu](sbatra@unmc.edu) (S.K.B.)  \n* [Correspondence: mbouvet@ucsd.edu](Correspondence: mbouvet@ucsd.edu); Tel.: +1-858-822-6191; Fax: +1-858-822-6192  \nAbstract: Claudins (CLDN1–CLDN24) are a family of tight junction proteins whose dysregulation has been implicated in tumorigeneses of many cancer types. In colorectal cancer (CRC), CLDN1, CLDN2, CLDN4, and CLDN18 have been shown to either be upregulated or aberrantly expressed. In the normal colon, CLDN1 and CLDN3–7 are expressed. Although a few claudins, such as CLDN6 and CLDN7, are expressed in CRC their levels are reduced compared to the normal colon. The present review outlines the expression profiles of claudin proteins in CRC and those that are potential biomarkers for prognostication.  \nKeywords: claudin; colorectal cancer; adenocarcinoma; expression; prognostics  \n1. Introduction  \nColorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States [1] . There are many factors that play a role in the malignant transformation of normal colonic mucosa. A central component of tumorigenesis is the epithelial-tomesenchymal transition (EMT), which was first described in 1982 by Greenburg et al. regarding its role in embryogenesis [2–5] . When a cell undergoes EMT, it loses its cell-to-cell adhesion and apical/basal polarity and instead gains the mesenchymal features of motility, invasiveness, and resistance to apoptosis [6] . However, this transition is incomplete, as it is exceedingly rare for carcinoma cells to lose all epithelial markers [7] . Additionally, this process can occur in the reverse, known as mesenchymal to epithelial transition (MET), and is thought to occur at the sites of distant metastases following dissemination [6] .  \nEMT involves the loss of cell-to-cell adhesion and apical/basal polarity. Tight junctions are responsible for these epithelial characteristics. The primary functions of tight junctions are to maintain cell polarity (known as the fence function) and regulate paracellular transport (known as the gate function) [8,9] . Altered or disrupted tight junction proteins have been implicated in tumorigenesis [2,9–11] .  \nClaudins and occludins are essential components of tight junctions, which are the most apical connection of epithelial and endothelial cells [2] . In 1998, Furuse et al. first discovered claudin-1 and claudin-2 and named them after the Latin word claudere, meaning“to close” [12] . The claudin family of proteins consists of twenty-four proteins, though the expression of claudin-13 and claudin-24 have yet to be found in human tissues. Claudins contain four transmembrane components, with the N-and C-termini ","cbCaiq0st8SmXMxJ","https://ap.wps.com/l/cbCaiq0st8SmXMxJ","pdf",9887462,24,"English","# Introduction\n## Tight junctions, EMT/MET, and tumorigenesis\n## Claudin family structure and regulation\n# Materials and Methods\n## Literature search window and criteria","[{\"question\":\"Which claudins are highlighted as dysregulated in colorectal cancer?\",\"answer\":\"CLDN1, CLDN2, CLDN4, and CLDN18 are described as upregulated or aberrantly expressed in colorectal cancer. Some claudins such as CLDN6 and CLDN7 are also expressed but at reduced levels compared with normal colon.\"},{\"question\":\"What is the reported expression pattern of claudins in normal colon?\",\"answer\":\"In normal colon, CLDN1 and CLDN3–7 are expressed. By contrast, CRC shows altered expression across several claudin subtypes.\"},{\"question\":\"How does the review assess claudins as prognostic biomarkers in CRC?\",\"answer\":\"The review outlines claudin expression profiles in CRC and focuses on claudins that have been proposed as potential biomarkers for prognostication, linking differential expression patterns to outcomes.\"}]","The Expression of the Claudin Family of Proteins in Colorectal Cancer - Review | PDF",1790007632]